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Abstract
Background: Islets of Langerhans transplantation is a promising therapy for type 1 diabetes mellitus, but this
technique is compromised by transplantation stresses including inflammation. In other tissues, co-transplantation
with mesenchymal stem cells has been shown to reduce damage by improving anti-inflammatory and anti-oxidant
defences. Therefore, we probed the protection afforded by bone marrow mesenchymal stem cells to islets under
pro-inflammatory cytokine stress.
Methods: In order to evaluate the cytoprotective potential of mesenchymal stem cells on rat islets, co-cultures
were exposed to the interleukin-1, tumour necrosis factor α and interferon γ cocktail for 24 h. Islet viability and
functionality tests were performed. Reactive oxygen species and malondialdehyde were measured. Expression of
stress-inducible genes acting as anti-oxidants and detoxifiers, such as superoxide dismutases 1 and 2, NAD(P)H
quinone oxidoreductase 1, heme oxygenase-1 and ferritin H, was compared to non-stressed cells, and the
corresponding proteins were measured. Data were analysed by a two-way ANOVA followed by a Holm-Sidak post
hoc analysis.
Results: Exposure of rat islets to cytokines induces a reduction in islet viability and functionality concomitant with
an oxidative status shift with an increase of cytosolic ROS production. Mesenchymal stem cells did not significantly
increase rat islet viability under exposure to cytokines but protected islets from the loss of insulin secretion. A
drastic reduction of the antioxidant factors heme oxygenase-1 and ferritin H protein levels was observed in islets
exposed to the cytokine cocktail with a prevention of this effect by the presence of mesenchymal stem cells.
Conclusions: Our data evidenced that MSCs are able to preserve islet insulin secretion through a modulation of the
oxidative imbalance mediated by heme and iron via heme oxygenase-1 and ferritin in a context of cytokine exposure.
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Background
Islet transplantation is a cell therapy proposed to patients
with brittle type 1 diabetes (T1D) experiencing severe
hypoglycemia. Islet transplantation efficiency has been
demonstrated to enhance glycemic control in T1D pa-
tients [1, 2], but several hurdles still need to be overcome.
The amount of engrafted islets is a key point determining
the graft outcome. Unfortunately, 50–70% of islet grafts
are lost in the early post-transplant period due to various
factors such as ischemia reperfusion, immunosuppressive
therapy toxicity or instant blood-mediated inflammatory
reaction mediated by pro-inflammatory cytokines [3].
Due to their poor oxidative defences [4, 5], islets are par-
ticularly sensitive to oxidative stress induced by inflamma-
tory cytokines [6–8]. A recent study has shown that the
overexpression of cytosolic superoxide dismutase (SOD1, a
key antioxidant enzyme) in an insulin-secreting cell line en-
hanced cell viability after exposure to cytokines [9]. The
Nrf2/ARE pathway, through the detoxifying enzymes
NAD(P)H quinone oxidoreductase 1 (NQO1), a cytosolic
two-electron reductase, and heme oxygenase-1 (HO-1), a
ubiquitous enzyme identified as a stress-inducible antioxi-
dant mediator, is implicated in the regulation of the oxida-
tive status of islets [10, 11]. HO-1 is studied for its possible
beneficial effect in transplantation [12]. Its overexpression
by transfection or chemical induction leads to reduced islet
sensitivity to oxidative stress induced by inflammatory cyto-
kines [13–15].
Among strategies suggested to protect islets against in-
flammation and to enhance islet graft viability, islet
co-transplantation with mesenchymal stem cells (MSCs)
is a promising approach as MSCs have demonstrated a
beneficial effect on islet survival and functionality in
vitro [16, 17] and on the islet graft function in vivo [18–
21]. MSCs partly prevent islet damage resulting from ex-
posure to cytokines in vitro [22]. In vivo, MSCs reduce
the inflammatory response in an intramuscular islet graft
model [23]. Interestingly, MSCs are described to alleviate
direct inhibition of antioxidant enzymes in different in-
flammatory diseases. Indeed, in a murine colitis model,
it has been shown that MSC transplantation prevents
the decrease in SOD1 activity induced by inflammation
[24]. Similarly, MSCs upregulate HO-1 and NQO1 gene
expression [24, 25] in various inflammatory disease
models. In an islet transplantation model, it has been
demonstrated that MSCs decrease reactive oxygen spe-
cies (ROS) generation induced by hypoxia [26]. Al-
though islet/MSC co-transplantation beneficial effects
are well documented, the impact of MSCs on the anti-
oxidant defences of islets exposed to inflammation has
not been previously investigated.
Our aim was thus to assess the oxidative status of
cytokine-exposed rat islets and to identify on which fac-
tors MSCs rely to preserve islet function and viability.
Materials and methods
Rat islet isolation procedure and animal approval
Rat islet isolation was performed in accordance with the
European Council Directive 2010/63/UE and the recom-
mendations of the French Ministry of Agriculture
(2013-118) on the care and use of laboratory animals.
Procedures were approved (n°9998_LBFA-U1055) by the
local ethics committee and agreed by the French Minis-
try of Research. All protocols were carried out in the
animal facility of the Department of Biology of the Uni-
versity (D3842110001). Rat islet isolation was performed
as previously described [27]. Briefly, a cannula was
inserted in the rat’s Wirsung duct to perfuse with colla-
genase type IX, 1 mg ml− 1 (Sigma-Aldrich, St. Louis,
MO, USA). Perfused pancreas was removed and digested
in a warm bath at 37 °C for 11 min. The digested pan-
creas was washed three times with a solution composed
of Hank’s balanced salt solution (HBSS) (Pan Biotech,
Aidenbach, Germany) supplemented with 10% of foetal
bovine serum (FBS) (Sigma-Aldrich, St. Louis, MO,
USA). Islets were purified by Histopaque (Sigma-Al-
drich, St. Louis, MO, USA) density gradient centrifuga-
tion. After three additional washes by sedimentation to
eliminate residual exocrine tissue, the islet pellet ob-
tained is resuspended in 1 ml of RPMI 1640 medium
(Thermo Fisher Scientific, Waltham, MA, USA) supple-
mented with 10% foetal bovine serum (Sigma-Aldrich,
St. Louis, MO, USA), 2 mM L-glutamine, 100 U ml− 1
penicillin, 100 μg ml− 1 streptomycin and 1mM sodium
pyruvate (Pan Biotech, Aidenbach, Germany). One twen-
tieth of this suspension is taken and seeded in a grid box
containing 2 ml of medium and 200 μl of dithizone 0.4
mg ml− 1 in dimethyl sulfoxide (DMSO) solution. This
solution permits to differentiate the endocrine tissue
(i.e., the islets) from the exocrine tissue. Under micros-
copy, the islets are counted, measured and converted
into islet equivalent (IEQ). One IEQ corresponds to the
tissue volume of a perfectly spherical islet with a diam-
eter of 150 μm. This procedure standardizes islet volume
measurements and ensures a distribution of an equiva-
lent islet volume between each condition. The rest of
the islet suspension was seeded. Isolated islets were in-
cubated at 37 °C in a humidified atmosphere (95% air,
5% CO2) for 12 h before co-culture with MSCs. Then
IEQs were randomly distributed between each condition.
The IEQ number used for each experiment varied in
function of the amount necessary for the analysis.
Human mesenchymal stem cell isolation and culture
MSCs were provided by the Cell Therapy and Engineer-
ing Unit of EFS Auvergne-Rhône-Alpes. Cells were iso-
lated from the bone marrow aspirated from human
healthy donors who gave their written informed consent.
All procedures complied with the French public health
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code (Article L1241-1). MSC isolation was conducted as
previously described [28]. After thawing, MSCs were
seeded at 3500 cells/cm2. Cells were maintained in cul-
ture at 37 °C, 95% O2 and 5% CO2 in MEM alpha
medium (Sigma-Aldrich, St. Louis, MO, USA) supple-
mented by 10% foetal bovine serum (Sigma-Aldrich, St.
Louis, MO, USA), 2 mM Glutamax, 100 U/ml penicillin
and 100 μg/ml streptomycin (Thermo Fisher Scientific,
Waltham, MA, USA). The medium was changed every 3
to 4 days. Upon confluence, cells were dissociated with
Trypsin-EDTA (0.25%) (Thermo Fisher Scientific, Wal-
tham, MA, USA).
Mesenchymal stem cell characterization
The Cell Therapy and Engineering Unit of EFS Auvergne-
Rhône-Alpes provided pre-immunophenotyped MSCs with
anti-CD45-FITC, anti-CD14-FITC, anti-CD105-PE, anti-
CD90-APC and anti-CD73-PE-CY7 (Becton Dickinson
Franklin Lakes, NJ, USA) which were analysed by flow cy-
tometry according to the manufacturer’s instructions (data
not shown). To confirm MSC functionality, cells were differ-
entiated using induction media (Stempro differentiation kit,
Thermo Fisher Scientific, Waltham, MA, USA) for adipo-
cyte, chondrocyte and osteocyte formation and stained re-
spectively with Oil Red O, Alcian blue and Alizarin Red S.
Cell culture: HepG2 and A549
The cell lines, HepG2 derived from a human hepatocel-
lular carcinoma and A549 from adenocarcinomic human
alveolar basal epithelial, were selected for their human
origin, for their proliferative velocity close to MSCs and
for their non-pancreatic origin. The aim of these
co-culture experiments was to determine if the protect-
ive effect observed is specific of MSCs and to rule out a
protective effect due to unspecific cell-to-cell contact ef-
fect. The cells were provided by the Deutsche Sammlung
von Mikroorganismen und Zellkulturen (DSMZ) culture
collection. After thawing, HepG2 and A549 were culti-
vated as previously described [29, 30]. Briefly, HepG2
and A549 were seeded at a density of 2.7 × 104 and 1.2 ×
104 cells/cm2 respectively. Cells were maintained in cul-
ture at 37 °C, 95% O2 and 5% CO2 in Dulbecco’s MEM
(Thermo Fisher Scientific, Waltham, MA, USA) supple-
mented with 10% FBS (Sigma-Aldrich, St. Louis, MO,
USA), 2mML-glutamine, 100 U/ml penicillin and 100 μg/
ml streptomycin (Pan Biotech, Aidenbach, Germany). The
medium was changed every 2 to 3 days. Upon confluence,
cells were treated with Trypsin-EDTA (0.25%) (Thermo
Fisher Scientific, Waltham, MA, USA).
Co-culture and exposure to cytokines
MSCs, HepG2 and A549 were seeded 12 h before
co-culture to allow cells to adhere. Cells were seeded at
100,000 cells for 200 islet equivalents (IEQs) to reach a
ratio of 500 cells/IEQ in all cases. Rat islets were seeded
in co-culture with MSCs, or with HepG2 or A549, and
incubated in the complete RPMI medium for 24 h. For
cytokine exposure, rat islets in co-culture with MSCs or
not were incubated for 24 h in the complete RPMI
medium supplemented with 600 UI ml− 1 of IL-1 β, 6000
UI ml− 1 of IFN-γ and 6000 UI ml− 1 of TNF-α (Merck
Millipore, Burlington, MA, USA). The cytokine concen-
trations were determined through a dose-response ana-
lysis of islet viability exposed to different cytokine
concentration. (Additional file 1). We selected the con-
centration inducing a significant but not drastic mortal-
ity of islets (20–40%).
Assessment of islet viability
To discriminate viability of islet cells from MSCs, MSCs
were stained with PKH67 before seeding islets, accord-
ing to the manufacturer’s instructions (Sigma-Aldrich,
St. Louis, MO, USA; λexc\λem = 490/504 nm). After cyto-
kine exposure, islets co-cultured with MSCs were washed
with PBS, dissociated with trypsin 1× and collected in PBS
for a cytometric analysis of single-cell suspension. The
two cell types were stained with 1.5 × 10− 10 mol mL− 1 of
propidium iodide (PI) (Interchim, Montluçon, France),
(λex/λem = 545/630) allowing identification of the nec-
rotic cells. Cells labelled with PI and PKH67 were consid-
ered as necrotic MSCs, unlabelled cells as viable islet cells
and cells stained with PI alone as necrotic islet cells. The
measurements were carried out using a FACS Calibur (BD
Bioscience, San Jose, CA, USA) instrument.
Glucose-stimulated insulin secretion test
To assess the insulin secretion capacity of islets, we per-
formed a glucose-stimulated insulin secretion (GSIS) test
adapted from a previously described protocol [31]. For
each condition tested, 200 rat IEQs were incubated at
37 °C, 95% O2 and 5% CO2 for 1 h in 2ml KREBS buffer
1% BSA and 2.8 mM glucose. Thereafter, islets were in-
cubated for 1 h with 2.8 mM glucose solution and for 1 h
with 16.7 mM glucose solution. After each incubation
step, supernatants were collected. Insulin concentration
in each collected medium was measured using a com-
mercial radioimmunoassay kit for rat insulin (Merck
Millipore Corporation, Germany). Insulin measurements
were performed by the Grenoble Biology and Pathology
Institute.
Measurement of cytosolic and mitochondrial reactive
species in islet cells
One hundred IEQs were dissociated with Trypsin-EDTA
(0.25%) and incubated for 30 min with 25 μM of
Carboxy-H2DCFDA (λexc\λem = 504/529 nm) (Inter-
chim, Montluçon, France) or 5 μM of MitoSOX red
(λexc\λem = 510/580 nm) (Invitrogen, Carlsbad, CA,
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USA). Carboxy-H2DCFDA is a non-specific indicator of
the cytosolic reactive oxygen species (ROS) and reactive
nitrogen species (RNS) such as hydrogen peroxide
(H2O2) and peroxynitrite anion (ONOO
−). MitoSOX
Red staining is an indicator of the production of super-
oxide (O2
−) generated inside the mitochondria. The ROS
content of each cellular compartment was expressed as
average signal intensity measured by flow cytometry.
Lipid peroxidation measurement
Lipid peroxidation was quantified by measuring malon-
dialdehyde (MDA). Briefly, 400 rat IEQs were disinte-
grated by 5 freezing/thawing cycles in 250 μl of Tris
hypotonic buffer. TBA reactive substances, including per-
oxidized lipids, were assayed using the 2-thiobarbituric
acid method as described previously [32].
RT-qPCR
Total RNA from 200 rat IEQs was purified using the
TriReagent kit (Applied Biosystems, Foster City, CA,
USA). Relative contents of target mRNA levels were de-
termined by reverse transcription followed by real-time
PCR using a Rotor-GeneTM 6000 (Corbett Research,
Saffron Walden, UK) with the primers reported in Add-
itional file 2. Each assay was performed in duplicate, and
values were normalized using hypoxanthine-guanine
phosphoribosyltransferase (HPRT).
Western blotting
Four hundred rat IEQs were lysed in RIPA buffer (Sigma-Al-
drich, St. Louis, MO, USA) supplemented with protease in-
hibitor cocktails (Roche, Basel, Switzerland). Proteins were
separated by SDS-10% PAGE (Biorad), transferred to nitro-
cellulose membranes and incubated overnight with the fol-
lowing primary antibodies: anti-superoxide dismutase 1
(SOD1) (1:2000), anti-NAD(P)H dehydrogenase (quinone 1)
(NQO1) (1:1000), anti-heme oxygenase 1 (HO-1) (1:1000)
and anti-ferritin H (FTH) (1:1000) (Abcam, Cambridge, UK).
The signals were detected with horseradish peroxidase-con-
jugated secondary antibodies: goat anti-rabbit IgG (1:10,000)
and goat anti-mouse IgG (Jackson ImmunoResearch, West
Grove, PA, USA), and revealed with an enhanced chemilu-
minescence system (Thermo Fisher). Due to our experimen-
tal conditions mimicking inflammation, we were unable to
find a stable protein as a loading control. To address this
issue, blot signals were normalized with Ponceau S staining
of each lane.
SOD activity assessment
For each condition, 800 rat IEQs were harvested and
disintegrated by 5 freezing/thawing cycles in 250 μl of
Tris hypotonic buffer. Total SOD, SOD1 and SOD2 ac-
tivities were measured as described previously [32] using
the pyrogallol assay.
Statistical analysis
To analyse MSCs’ impact on cytokine-exposed islets, data
from exposure to cytokine conditions were normalized on
control values. All the data were expressed as median ±
interquartile and represented in box plots. When data
were normally distributed, a two-way ANOVA was per-
formed. If significant, the omnibus test of variance was
followed by a Holm-Sidak post hoc analysis. For
non-parametric data, a log or square root transformation
was performed before the two-way ANOVA. The thresh-
old for significance was set at p < 0.05.
Results
MSCs exhibit conformity to phenotype and functionality
MSCs positive for CD44, CD73, CD90 and CD105 were
able to differentiate into adipocytes (stained by Oil Red
O), chondrocytes (stained by Alcian blue) and osteocytes
(stained by alizarin Red S) demonstrating their proper
functionality (Additional file 3).
MSCs co-cultured with islets protect insulin secretion but
not islet viability under exposure to cytokines
After exposure to cytokines, we observed a significant
decrease in islet viability with an islet viability of 64.8%
[60.4%–71.7%] in islets exposed to cytokines vs. 100%
[83.8–102.6%] in control islets (p < 0.001; n = 6). More-
over, cytokine exposure induced a significant reduction
of glucose-stimulated insulin secretion with an islet
stimulation index fold of 0.29 [0.26–0.40] in islets ex-
posed to cytokines vs. 1 [0.71–1.23] in control islets
(Fig. 1). (p < 0.001; n = 10) (Fig. 1).
MSCs co-cultured with islets did not statistically im-
pact viability of islets exposed to cytokines (72.5% [68.4–
82.9%]) compared to islets alone exposed to cytokines
(64.8% [60.4–71.7%]) (p = 0.21; n = 6) (Fig. 1a). Neverthe-
less, co-culture of islets with MSCs enhanced statistically
the stimulation index from 0.29 [0.26–0.40] in islets
alone exposed to cytokines to 0.67 [0.41–1.07] in islets
co-cultured with MSCs and exposed to cytokines (p =
0.004; n = 10) (Fig. 1b).
The positive effect observed on islet insulin secretion
is specific of MSC co-culture: no enhancement of insulin
secretion was observed when islets were co-cultured
with HepG2 and A549 cell lines seeded at the same
density (see Additional file 4).
MSCs partially restore antioxidant and anti-inflammatory
protein levels in islets under cytokine exposure
We investigated whether the implemented inflammatory
conditions were associated with a change in islet oxida-
tive status. While mitochondrial superoxide production
measured by MitoSOX fluorescence was not affected by
exposure to cytokines (Fig. 2b), we observed a significant
increase of cytosolic oxidative species from 1 [0.94–1.02]
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in islets not exposed to cytokines to 1.61 [1.36–1.65] in
islets exposed to cytokines (p < 0.002; n = 5, Fig. 2a).
MDA measurements showed that the increase of cyto-
solic oxidative species did not correlate with the increase
of thiobarbituric acid reactive species (Additional file 5),
implying that lipid peroxidation, a marker of advanced cell
damage, is not significantly induced by the cytokine stress.
MSCs co-cultured with islets did not prevent islet
cytosolic ROS and RNS production induced by cytokine
exposure (1.4 [1.4–1.6]) (p = 0.459; n = 5) (Fig. 2a, b).
MDA analysis confirmed the absence of advanced detri-
mental oxidative effect of exposure to cytokines also in
MSC co-cultures (Additional file 5).
To confirm the pro-oxidative shift in islets induced by
cytokines, we studied the islet antioxidant response fol-
lowing cytokine exposure. Regarding direct antioxidant
defences, cytokine exposure induced a significant de-
crease of SOD1 mRNA from 1 [0.98–1.15] in control is-
lets to 0.78 [0.72–0.80] (p < 0.001; n = 6) in
cytokine-exposed islets. A corresponding significant
SOD-1 protein level decrease is observed from 1 [0.89–
1.18] in control islets to 0.53 [0.24–0.69] in
cytokine-exposed islets (p = 0.006; n = 8) (Fig. 3a, b).
Cytokine exposure induced a strong and statistically sig-
nificant SOD2 mRNA overexpression from 1 [0.96–1.16]
in control islets to 21.49 [18.42–24.54] in
cytokine-exposed islets (p < 0.001; n = 6) (Fig. 3c). How-
ever, no change in SOD2 protein levels was observed in
cytokine-exposed islets as compared to control islets
a
b
Fig. 1 Mesenchymal stem cells effect on rat islet viability and insulin
secretion after exposure to cytokines. a Islet viability was assessed by
flow cytometry after PKH67/Propidium iodide double staining. Data are
representative of six independent experiments and are represented as
median ± interquartile (ANOVA; *p < 0.05 vs. respective controls
and #p < 0.05 vs. cytokine-exposed islets alone). b Stimulation
index was determined based on the insulin secretion response to
glucose stimulation. Data are representative of 10 independent
experiments and are represented as median ± interquartile
a
b
Fig. 2 Oxidative status evaluation of islets in different culture
conditions. a Cytosolic and b mitochondrial ROS assessment were
performed by flow cytometry using respectively Carbo-H2DCFDA
and MitoSOX probes. Data are representative of five independent
experiments and are represented as median ± interquartile (ANOVA;
*p < 0.05 vs. respective controls)
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(Fig. 3d). The total SOD activity statistically increased
from 1 [0.81–1.06] in control to 1.40 [1.16–1.56] in
cytokine-exposed islets (p = 0.003; n = 8) (Fig. 3e).
Regarding the MSCs’ impact on islet antioxidant re-
sponse under cytokine exposure, the presence of MSCs
restored islet SOD 1 gene expression close to the SOD1
level of control islets (1.01 [0.90–1.13] in islets
co-cultured with MSCs and exposed to cytokines vs. 1
[0.99–1.01] in control islets (p = 0.94; n = 6)) (Fig. 3a).
No effect of MSCs on SOD2 gene expression was ob-
served (Fig. 3c). Under cytokine exposure, MSC
co-culture did not impact islet SOD1 and SOD2 protein
levels nor SOD activity as compared to islets alone ex-
posed to cytokines (Fig. 3b, d, e).
Regarding NQO1, in cytokine-exposed islets, no
change in gene expression was observed as compared to
control islets, whereas NQO1 protein levels statistically
decreased after cytokine exposure (0.55 [0.41–0.76]) as
compared to control islets (1.00 [0.77–1.28]) (p = 0.024;
n = 8) (Fig. 4a, b). NQO1 gene expression in islets
co-cultured with MSCs and exposed to cytokines was
statistically increased (1.51 [1.33–1.55]) as compared to
islets alone exposed to cytokines (1.05 [0.89–1.16]; p =
0.006; n = 6) (Fig. 4a). No significant difference on the
NQO1 protein level in islets co-cultured with MSCs ex-
posed to cytokines was observed as compared to islets
alone exposed to cytokines (p = 0.469; n = 8) (Fig. 4b).
The HMOX1 mRNA level was significantly and
strongly increased in cytokine-exposed islets (5.70
[4.63–6.15]) as compared to control islets (1.00 [0.94–
1.22]; p < 0.001; n = 6) (Fig. 5a). However, a significant
decrease in the HO-1 protein level was observed in
cytokine-exposed islets (0.31 [0.27–0.35]) as compared
to control islets (1.00 [0.87–1.47]; p < 0.001; n = 8)
(Fig. 5b). In the same way, the FTH1 mRNA level in-
creased statistically in islets alone exposed to cytokines
(1.68 [1.44–2.14]) compared to control islets (1.00
[0.78–1.10]; p = 0.004; n = 6) while a significant decrease
in ferritin H protein levels was observed in islets alone
exposed to cytokines (0.52 [0.38–0.57]) vs. control islets
(1.00 [0.87–1.09]; p = 0.01; n = 8) (Fig. 5c, d).
In co-culture with MSCs, HMOX1 mRNA expression
tended to increase from 5.70 [4.63–6.15] in islets alone
exposed to cytokines to 6.64 [6.21–6.74] in islets
co-cultured with MSCs exposed to cytokines (p = 0.054;
n = 6). HO-1 protein levels were significantly increased
in islets co-cultured with MSCs exposed to cytokines
(0.86 [0.50–1.20]) as compared to islets alone exposed to
cytokines (0.31 [0.27–0.35]; p = 0.012; n = 8) (Fig. 5a, b).
Similarly, FTH1 mRNA expression was statistically in-
creased in islets co-cultured with MSCs exposed to cyto-
kines (2.76 [2.46–3.08]) as compared to islets alone
exposed to cytokines (1.68 [1.44–2.14]; p < 0.001; n = 6).
The ferritin H protein level was statistically increased in
islets co-cultured with MSCs exposed to cytokines (1.02
[0.69–1.46]) as compared to islets alone exposed to cyto-
kines (0.52 [0.38–0.57], p = 0.019, n = 8) (Fig. 5c, d).
Discussion
In this study, we showed that the loss of insulin secre-
tion induced by exposure to cytokines was partially pre-
vented by MSC co-culture. This effect is specific to
MSCs as evidenced by the results of co-culture with two
unrelated cell lines. MSCs helped islets in maintaining
the HO-1 and ferritin H protein levels under exposure
to cytokines which otherwise fell under this stress. These
results suggest that the HO-1/ferritin H pathway partici-
pates in the protective effect of MSCs on islet
functionality.
We demonstrated that under exposure to cytokines,
co-cultured islets exhibited better insulin secretion cap-
ability than control islets, while no effect was observed
on islet viability. If MSCs’ positive effect on islet func-
tionality in vitro is widely described [17], data on viabil-
ity of islets with MSCs are discordant and need to be
further explored. Some studies evidenced a positive im-
pact of MSCs on in vitro islet viability [22] whereas
others reported no differences on in vitro islet viability
when co-cultured with MSCs [33] probably depending
on cell culture conditions (time of culture, direct cell
contact vs. indirect co-culture system, stress induction)
as well as source of MSCs.
It was demonstrated that insulin secretion is widely
impacted by an overproduction of ROS in an inflamma-
tory context [34]. In our study, cytokine exposure exerts
a slight cytosolic but not mitochondrial ROS overpro-
duction. Regarding co-culture with MSCs, in our 24-h
cytokine exposure model, MSCs have no effect on islet
cytosolic ROS elevation. While in our model, cytosolic
ROS overproduction seems to not induce advanced oxi-
dative damages as illustrated by lipid peroxidation mea-
surements, cytokine exposure induces an oxidative
status shift that is confirmed by an antioxidant enzyme
response.
Regarding SODs, we observed two different response
patterns. SOD1 mRNA and protein are slightly downreg-
ulated by cytokine exposure as previously described in
other stress models [35, 36]. On the other hand, SOD2
seems to be more sensitive and islet cytokine exposure
results in a rapid increase of its transcriptional and
translational level as previously described [35, 36]. In
our model, the presence of MSCs only restores the tran-
scriptional level of SOD1 with no effect on SOD2 gene,
protein expression nor activity.
Few studies have been conducted to evaluate the role
of NQO1 in the mechanisms involved in the islet protec-
tion against oxidative stress [37]. It was reported that
the protective effect of curcumin and Nrf2 activation
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induced by dh404 is accompanied by an increase in
NQO1 expression at the mRNA and protein level
[10, 38]. Interestingly, in our model, NQO1 gene ex-
pression seems to be naturally non-sensitive to cyto-
kine exposure. On the other hand, MSCs modestly
stimulate NQO1 mRNA expression. This observation
is consistent with the literature that showed, in a
pulmonary fibrosis model, an upregulation of NQO1
mRNA in the presence of MSCs [14]. However, re-
garding protein regulation in our model, cytokine
exposure induced a slight NQO1 decrease not pre-
vented by the MSC co-culture.
The difference between transcriptional response and
translational response of the different enzymes exposed
to cytokines and in the presence of MSCs has to be
noted. These observations could suggest the establish-
ment of post-transcriptional regulations that are not pre-
vented by the presence of MSCs or a longer kinetic of
regulation longer preventing the observation of the MSC
effect at a protein level.
a b
c d
Fig. 3 MSCs’ effect on cytokine-exposed rat islet’s superoxide dismutases 1 and 2. a, c Transcripts were measured by RT-PCR and values were
normalized on HPRT. b, d Quantitative analysis of proteins normalized with Ponceau S staining of the whole lane. e SOD activity was determined using
the pyrogallol assay. Data are representative of six independent experiments for RT-PCR analysis and eight for western blot analysis and SOD activity.
Data are represented as median ± interquartile (ANOVA; *p < 0.05 vs. respective controls and #p < 0.05 vs. cytokine-exposed islets alone)
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In our study, we demonstrated that MSCs induced
preservation of HO-1 and ferritin H protein levels in is-
lets exposed to cytokines. Our data are consistent with
the literature evidencing an impact of MSCs on HO-1
upregulation in different cells and stress conditions. Spe-
cifically, MSCs are described to damper inflammation in
a rat model of acute liver failure by inducing HO-1 up-
regulation [25]. In the same way, a study showed
upregulation of HO-1 by MSCs in a pulmonary fibrosis
model [39]. In islets, MSCs improved islet resistance
against hypoxia/reoxygenation through increase of HO-1
expression [40].
HO-1 upregulation has been previously described to
confer anti-apoptotic and anti-inflammatory properties
to various cell lines and tissues including islets. In islets,
HO-1 upregulation or overproduction has been de-
scribed to enhance insulin release of islets in vitro [41]
and to enhance islet graft function in vivo [42]. HO-1
degrades heme, a strong oxidative moiety when released
in cells, into ferrous iron, biliverdin (BV) and carbon
monoxide (CO). These last two heme catabolites have
been described in previous publications [43] for their
own antioxidant, anti-inflammatory and anti-apoptotic
properties. BV reductase converts BV in bilirubin (BR)
that showed anti-inflammatory properties in an islet iso-
lation and transplantation procedure [44, 45]. CO is a
cell signalling activator of anti-inflammatory pathways
by modulating guanylate cyclase and activating the
mitogen-activated protein kinase (MAPK) pathways [46].
Consequently, considering the negative impact of in-
flammation on islet insulin secretion [47], HO-1 could
improve inflammation status of the islets and subse-
quent insulin secretion capacity by activating the
anti-inflammatory response. Moreover, the HO-1/CO
pathway was identified as an insulin secretion stimulator
by the activating the cGMP pathway [48], and CO was
described to act as a messenger that potentiates insulin
secretion by propagating Ca2+ signals between β cells
[49]. Our results show that MSCs contribute to maintain
the insulin secretion capacity observed in islets exposed
to cytokines through enhanced HMOX1 expression and
preservation of HO-1 levels.
Mechanisms by which MSCs restore HO-1 protein
levels need to be clarified. It was demonstrated that HO-1
protein levels were regulated at the post-transcriptional
level by nitric oxide (NO) that stabilizes HO-1 mRNA by
preventing its deadenylation [50] thus enhancing the
mRNA half-life and, consequently, translation. In prelim-
inary experiments, we observed that exposure to cytokines
upregulated inducible nitric oxide synthase (iNOS) mRNA
in islets (see Additional file 6), but no differences in iNOS
mRNA levels were observed in the presence of MSCs.
Thus, the restoration of the HO-1 protein level in the
presence of MSCs is unlikely to be mediated by NO. The
pathways by which ferritin H is regulated are extensively
described [51]. FTH1 is transcriptionally controlled by
Nrf2 which may explain the concomitant increase of
FTH1 mRNA and HO-1 expression with NQO-1 expres-
sion in our study. Further experiments analysing the Nrf2
pathway activation could be of interest to clarify its in-
volvement in the MSC protective effects. The translation
of ferritin H is inhibited by the iron regulatory proteins
a
b
Fig. 4 MSCs’ effect on cytokine-exposed rat islet’s NAD(P)H
dehydrogenase (quinone 1) expression. a Transcripts were measured
by RT-PCR and values were normalized on HPRT. b Blot signals were
normalized with Ponceau S staining of the whole. Data are
representative of six independent experiments for RT-PCR analysis
and eight for western blot analysis and are represented as median ±
interquartile (ANOVA; *p < 0.05 vs. respective controls and #p < 0.05
vs. stressed islets alone)
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(IRP) which bind to the iron regulatory elements (IRE) lo-
cated in the 5′ untranslated region of the mRNA of the
ferritin subunits [46]. The combined observations of
HMOX-1 overexpression and the preservation of the pro-
tein level in the presence of MSCs under the cytokine
stress (Fig. 5a, b) may signal the need for sustained activ-
ity, hence significant production of the substrates. Among
them, liberated ferrous iron must be properly handled by
cells to avoid increased oxidative stress. This is one of the
main functions of ferritin in agreement with the preserva-
tion of its level in the presence of MSCs (Fig. 5c, d). The
decreased or preserved IRP activity associated with the re-
lease of iron by heme oxygenase may thus contribute to
the maintenance of the ferritin levels in an exquisitely sen-
sitive phenomenon occurring with minor variations of the
iron concentrations [52]. This provides another regulatory
mechanism at the translational level which can complete
the transcriptional one afforded by Nrf2 to keep ferritin at
a level allowing it to protect islets under the cytokine
challenge.
Here, we analysed the impact of MSC on antioxidant de-
fences in an in vitro model. Effects of MSC on islet, in vivo,
are multifactorial and have been previously described with
paracrine effects [22], anti-inflammatory effects [23],
pro-angiogenic effects [53] and immunomodulatory effects
[54]. The anti-oxidant effects participate, among the others,
a b
c d
Fig. 5 MSCs stimulate heme oxygenase 1 and the downstream ferritin heavy-chain subunit in cytokinic stress conditions. a, c Transcripts were
measured by RT-PCR and values were normalized on HPRT. b, d Blot signals were normalized with Ponceau S staining of the whole lane. Data are
representative of six independent experiments for RT-PCR analysis and eight for western blot analysis and are represented as median ± interquartile
(ANOVA; *p < 0.05 vs. respective controls and #p < 0.05 vs. stressed islets alone)
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to the positive effects of MSCs. Future experiments should
be performed, in vivo, to analyse in a model of islet trans-
plantation the effect of MSCs on oxidative status of islets.
Conclusions
To conclude, our data evidenced that MSCs are able to
enhance islet insulin secretion in vitro under cytokine
exposure and to preserve HO-1 and ferritin H protein
levels. This work opens new perspectives in the multiple
mechanisms underlying MSC protection. It highlights
the impact of MSCs on islet oxidative imbalance. Fur-
ther in vivo studies will be necessary to analyse the im-
pact of antioxidant defence modulation by MSCs on
islet physiology.
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